IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Performance
Performance Report
Akums Drugs and Pharmaceuticals IPO is a Book Building IPO listing on BSE,NSE exchange, with an ipo size of ₹ 1856.74 Cr. The company is based in New Delhi and caters to Pharmaceutical sector. Ambit , Axis Bank , Citigroup Global Markets India , ICICI Securities are the merchant bankers of Akums Drugs and Pharmaceuticals IPO. It is a MainBoard IPO which filed its Draft Red Herring Prospectus (DRHP) on 10th February 2024.
Akums Drugs and Pharmaceuticals IPO open date is 30th July 2024 and close date is 1st August 2024. IPO Allotment Date is 2nd August 2024 and Listing date is 6th August 2024.
IPO
Size:
₹ 1856.74 Cr.
Avg IPO Size (Sector Based)
: ₹
1,342.04 cr.
Sector: Pharmaceutical
IPO so far:
22
Merchant Banker:
Ambit Private
IPO by BRLM so far:
16
City:
New Delhi
IPO so far:
123
Revenue (annualised):
₹
4212.21
cr. 
PE
Ratio:
29.79x
Average Sector PE Ratio: 25.12x
Akums Drugs and Pharmaceuticals IPO size is ₹ 1856.74 Cr. with IPO price of ₹ 679.00. IPO subscription will start on IPO open date and end on IPO close date as per above. IPO valuation metrics can be seen here.
Ambit Private Limited is the book-running lead manager of the Akums Drugs and Pharmaceuticals IPO. Link Intime India Private Limited is the Registrar for Akums Drugs and Pharmaceuticals IPO.
Akums Drugs and Pharmaceuticals IPO Draft red herring prospectus (DRHP) and Red Herring prospectus (RHP) are available below.
Akums Drugs and Pharmaceuticals IPO, based in New Delhi, operates in the Pharmaceutical sector with a focus on Pharmaceuticals. The company is launching its MainBoard IPO on the BSE,NSE exchange, using the Book Building Issue method. Akums Drugs and Pharmaceuticals IPO size is ₹ 1856.74 Cr. with fresh issue size of ₹ 680.00 Cr. and Offer for sale being ₹ 1176.74Cr.
The IPO allotment date for Akums Drugs and Pharmaceuticals IPO is expected to be 2nd August 2024, after the finalization of basis of allotment. Investors can check Akums Drugs and Pharmaceuticals IPO allotment status on the registrars website, Link Intime India Private Limited . Akums Drugs and Pharmaceuticals IPO refund dates are 5th August 2024.
Akums Drugs and Pharmaceuticals IPO is expected to be listed on 6th August 2024.
The upper price band for the Akums Drugs and Pharmaceuticals IPO is set at ₹ 679.00 per equity share. IPO price band is arrived at on the basis of IPO Valuation (P/E multiple) which is mentioned in the RHP.
For IPO analysis on Akums Drugs and Pharmaceuticals IPO, explore our Financial Review Page for insights on fundamentals, peer analysis, and key IPO data, assisting investors to make informed decisions to apply or not.
To apply for the Akums Drugs and Pharmaceuticals IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of 1st August 2024. After submission, funds are blocked until the basis of allotment of Akums Drugs and Pharmaceuticals IPO is finalised.
The merchant banker for Akums Drugs and Pharmaceuticals IPO is Ambit Private Limited , Axis Bank Limited , Citigroup Global Markets India Private Limited , ICICI Securities Limited . Ambit Private Limited , Axis Bank Limited , Citigroup Global Markets India Private Limited , ICICI Securities Limited manages the IPO process, including underwriting, regulatory compliance, and investor coordination. Investors can refer to the Akums Drugs and Pharmaceuticals IPO RHP for further details.
The registrar for Akums Drugs and Pharmaceuticals IPO is Link Intime India Private Limited . Investors can go to Link Intime India Private Limited registrar website for IPO allotment status, refund processing, and other queries related to Akums Drugs and Pharmaceuticals IPO through their official website or helpline.
Akums Drugs and Pharmaceuticals IPO was subscribed 63.44 times. Stay updated on IPO details, subscription, and allotment news for informed investment decisions.
IPO
Size:
₹ 1856.74 Cr.
Avg IPO Size (Sector Based)
:
₹ 1,342.04 Cr.
Sector: Pharmaceutical
IPO so far:
22
Merchant Banker:
Ambit Private
IPO by BRLM so far:
16
City:
New Delhi
IPO so far:
123
Revenue (annualised):
₹ 4,178.18 cr.
PE
Ratio:
29.79x
Average Sector PE Ratio: 25.12x
Akums Drugs and Pharmaceuticals IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Akums Drugs and Pharmaceuticals Financial Review Page
Merchant Banker(s) of Akums Drugs and Pharmaceuticals IPO: Ambit Private Limited , Axis Bank Limited , Citigroup Global Markets India Private Limited , ICICI Securities Limited
Akums Drugs and Pharmaceuticals IPO subscription was 63.44 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Akums Drugs and Pharmaceuticals IPO listed at a listing price of 796.35 against the offer price of 679.00.
The current market price of Akums Drugs and Pharmaceuticals is 569.35.
Why Us?
